• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同的非同义多态性调节WRN蛋白与其蛋白质伴侣的相互作用及其酶活性。

Different non-synonymous polymorphisms modulate the interaction of the WRN protein to its protein partners and its enzymatic activities.

作者信息

Gagné Jean-Philippe, Lachapelle Sophie, Garand Chantal, Tsofack Serges P, Coulombe Yan, Caron Marie-Christine, Poirier Guy G, Masson Jean-Yves, Lebel Michel

机构信息

Centre de Recherche du CHU de Québec, Pavillon CHUL Université Laval, Faculté de Médecine, Québec, Canada.

Centre de Recherche sur le Cancer de l'Université Laval, Hôpital Hôtel-Dieu de Québec, Québec, Québec, Canada.

出版信息

Oncotarget. 2016 Dec 27;7(52):85680-85696. doi: 10.18632/oncotarget.13341.

DOI:10.18632/oncotarget.13341
PMID:27863399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5349866/
Abstract

Werner syndrome (WS) is characterized by the premature onset of several age-associated pathologies including cancer. The protein defective in WS patients (WRN) is a helicase/exonuclease involved in DNA replication and repair. Here, we present the results of a large-scale proteome analysis that has been undertaken to determine protein partners of different polymorphic WRN proteins found with relatively high prevalence in the human population. We expressed different fluorescently tagged-WRN (eYFP-WRN) variants in human 293 embryonic kidney cells (HEK293) and used a combination of affinity-purification and mass spectrometry to identify different compositions of WRN-associated protein complexes. We found that a WRN variant containing a phenylalanine residue at position 1074 and an arginine at position 1367 (eYFP-WRN(F-R)) possesses more affinity for DNA-PKc, KU86, KU70, and PARP1 than a variant containing a leucine at position 1074 and a cysteine at position 1367 (eYFP-WRN(L-C)). Such results were confirmed in a WRN-deficient background using WS fibroblasts. Interestingly, the exonuclase activity of WRN recovered from immunoprecipitated eYFP-WRN(L-C) variant was lower than the eYFP-WRN(F-R) in WS cells. Finally, HEK293 cells and WS fibroblasts overexpressing the eYFP-WRN(F-R) variant were more resistant to the benzene metabolite hydroquinone than cells expressing the eYFP-WRN(L-C) variant. These results indicate that the protein-protein interaction landscape of WRN is subject to modulation by polymorphic amino acids, a characteristic associated with distinctive cell survival outcome.

摘要

沃纳综合征(WS)的特征是包括癌症在内的多种与年龄相关的病理状况过早出现。WS患者中存在缺陷的蛋白质(WRN)是一种参与DNA复制和修复的解旋酶/核酸外切酶。在此,我们展示了一项大规模蛋白质组分析的结果,该分析旨在确定在人群中相对高频率发现的不同多态性WRN蛋白的蛋白质伴侣。我们在人293胚胎肾细胞(HEK293)中表达了不同的荧光标记WRN(eYFP-WRN)变体,并使用亲和纯化和质谱联用技术来鉴定WRN相关蛋白复合物的不同组成。我们发现,在第1074位含有苯丙氨酸残基且在第1367位含有精氨酸的WRN变体(eYFP-WRN(F-R))比在第1074位含有亮氨酸且在第1367位含有半胱氨酸的变体(eYFP-WRN(L-C))对DNA-PKc、KU86、KU70和PARP1具有更高的亲和力。使用WS成纤维细胞在WRN缺陷背景下证实了这些结果。有趣的是,从免疫沉淀的eYFP-WRN(L-C)变体中回收的WRN的核酸外切酶活性在WS细胞中低于eYFP-WRN(F-R)。最后,与表达eYFP-WRN(L-C)变体的细胞相比,过表达eYFP-WRN(F-R)变体的HEK293细胞和WS成纤维细胞对苯代谢物对苯二酚更具抗性。这些结果表明,WRN的蛋白质-蛋白质相互作用格局受到多态性氨基酸的调节,这一特征与独特的细胞存活结果相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/5349866/e3c84986c185/oncotarget-07-85680-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/5349866/ed3b83e31bd0/oncotarget-07-85680-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/5349866/a907617bc4c0/oncotarget-07-85680-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/5349866/e395ed8483e0/oncotarget-07-85680-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/5349866/09f3006f4e71/oncotarget-07-85680-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/5349866/484d6ba4802c/oncotarget-07-85680-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/5349866/e3c84986c185/oncotarget-07-85680-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/5349866/ed3b83e31bd0/oncotarget-07-85680-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/5349866/a907617bc4c0/oncotarget-07-85680-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/5349866/e395ed8483e0/oncotarget-07-85680-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/5349866/09f3006f4e71/oncotarget-07-85680-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/5349866/484d6ba4802c/oncotarget-07-85680-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/5349866/e3c84986c185/oncotarget-07-85680-g006.jpg

相似文献

1
Different non-synonymous polymorphisms modulate the interaction of the WRN protein to its protein partners and its enzymatic activities.不同的非同义多态性调节WRN蛋白与其蛋白质伴侣的相互作用及其酶活性。
Oncotarget. 2016 Dec 27;7(52):85680-85696. doi: 10.18632/oncotarget.13341.
2
Proteome-wide identification of WRN-interacting proteins in untreated and nuclease-treated samples.未处理和核酸酶处理样品中 WRN 相互作用蛋白的蛋白质组学鉴定。
J Proteome Res. 2011 Mar 4;10(3):1216-27. doi: 10.1021/pr100990s. Epub 2011 Feb 16.
3
Werner Syndrome Protein and DNA Replication. Werner 综合征蛋白与 DNA 复制。
Int J Mol Sci. 2018 Nov 2;19(11):3442. doi: 10.3390/ijms19113442.
4
Homozygosity for the WRN Helicase-Inactivating Variant, R834C, does not confer a Werner syndrome clinical phenotype.WRN 解旋酶失活变异型 R834C 的纯合子并不导致 Werner 综合征临床表型。
Sci Rep. 2017 Mar 9;7:44081. doi: 10.1038/srep44081.
5
Poly(ADP-ribose) polymerase 1 regulates both the exonuclease and helicase activities of the Werner syndrome protein.聚(ADP - 核糖)聚合酶1调节沃纳综合征蛋白的核酸外切酶和解旋酶活性。
Nucleic Acids Res. 2004 Aug 3;32(13):4003-14. doi: 10.1093/nar/gkh721. Print 2004.
6
Vitamin C alters the amount of specific endoplasmic reticulum associated proteins involved in lipid metabolism in the liver of mice synthesizing a nonfunctional Werner syndrome (Wrn) mutant protein.维生素 C 改变了在合成无功能 Werner 综合征 (Wrn) 突变蛋白的小鼠肝脏中参与脂代谢的特定内质网相关蛋白的数量。
PLoS One. 2018 Mar 1;13(3):e0193170. doi: 10.1371/journal.pone.0193170. eCollection 2018.
7
The non-synonymous polymorphism at position 114 of the WRN protein affects cholesterol efflux in vitro and correlates with cholesterol levels in vivo.WRN 蛋白第 114 位的非同义多态性影响体外胆固醇流出,与体内胆固醇水平相关。
Exp Gerontol. 2013 Jun;48(6):533-8. doi: 10.1016/j.exger.2013.03.003. Epub 2013 Mar 21.
8
Werner Syndrome Protein Expression in Breast Cancer.乳腺癌中的沃纳综合征蛋白表达
Clin Breast Cancer. 2021 Feb;21(1):57-73.e7. doi: 10.1016/j.clbc.2020.07.013. Epub 2020 Jul 25.
9
The Werner syndrome protein has separable recombination and survival functions.
DNA Repair (Amst). 2004 May 4;3(5):475-82. doi: 10.1016/j.dnarep.2004.01.002.
10
Enzymatic mechanism of the WRN helicase/nuclease.WRN解旋酶/核酸酶的酶促机制。
Methods Enzymol. 2006;409:52-85. doi: 10.1016/S0076-6879(05)09004-X.

本文引用的文献

1
The Ku-binding motif is a conserved module for recruitment and stimulation of non-homologous end-joining proteins.Ku结合基序是用于募集和刺激非同源末端连接蛋白的保守模块。
Nat Commun. 2016 Apr 11;7:11242. doi: 10.1038/ncomms11242.
2
Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.聚(ADP-核糖)聚合酶1和聚(ADP-核糖)在调节WRN和RECQL5活性中的差异作用与协同作用
Mol Cell Biol. 2015 Dec;35(23):3974-89. doi: 10.1128/MCB.00427-15. Epub 2015 Sep 21.
3
RecQ helicases and PARP1 team up in maintaining genome integrity.
RecQ 解旋酶与 PARP1 协同作用维持基因组完整性。
Ageing Res Rev. 2015 Sep;23(Pt A):12-28. doi: 10.1016/j.arr.2014.12.006. Epub 2014 Dec 30.
4
Structural mechanisms of human RecQ helicases WRN and BLM.人类RecQ解旋酶WRN和BLM的结构机制。
Front Genet. 2014 Oct 29;5:366. doi: 10.3389/fgene.2014.00366. eCollection 2014.
5
Cellular deficiency of Werner syndrome protein or RECQ1 promotes genotoxic potential of hydroquinone and benzo[a]pyrene exposure.沃纳综合征蛋白或RECQ1的细胞缺陷会增强接触对苯二酚和苯并[a]芘的遗传毒性。
Int J Toxicol. 2014 Sep-Oct;33(5):373-81. doi: 10.1177/1091581814547422. Epub 2014 Sep 15.
6
Serines 440 and 467 in the Werner syndrome protein are phosphorylated by DNA-PK and affects its dynamics in response to DNA double strand breaks.沃纳综合征蛋白中的丝氨酸440和467被DNA依赖性蛋白激酶磷酸化,并影响其对DNA双链断裂的反应动力学。
Aging (Albany NY). 2014 Jan;6(1):70-81. doi: 10.18632/aging.100629.
7
BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency.BMN 673,一种新型高效的 PARP1/2 抑制剂,用于治疗具有 DNA 修复缺陷的人类癌症。
Clin Cancer Res. 2013 Sep 15;19(18):5003-15. doi: 10.1158/1078-0432.CCR-13-1391. Epub 2013 Jul 23.
8
Spectrum and risk of neoplasia in Werner syndrome: a systematic review.沃纳综合征的肿瘤谱及风险:一项系统性回顾。
PLoS One. 2013;8(4):e59709. doi: 10.1371/journal.pone.0059709. Epub 2013 Apr 1.
9
Reprogramming cellular events by poly(ADP-ribose)-binding proteins.通过聚(ADP-核糖)结合蛋白重编程细胞事件。
Mol Aspects Med. 2013 Dec;34(6):1066-87. doi: 10.1016/j.mam.2012.12.005. Epub 2012 Dec 23.
10
Site-specific noncovalent interaction of the biopolymer poly(ADP-ribose) with the Werner syndrome protein regulates protein functions.聚(ADP-核糖)与 Werner 综合征蛋白的特定部位非共价相互作用调节蛋白质功能。
ACS Chem Biol. 2013 Jan 18;8(1):179-88. doi: 10.1021/cb300363g. Epub 2012 Oct 29.